Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma.

Kim HL, Seligson D, Liu X, Janzen N, Bui MH, Yu H, Shi T, Belldegrun AS, Horvath S, Figlin RA.

J Urol. 2005 May;173(5):1496-501.

PMID:
15821467
2.

Using protein expressions to predict survival in clear cell renal carcinoma.

Kim HL, Seligson D, Liu X, Janzen N, Bui MH, Yu H, Shi T, Figlin RA, Horvath S, Belldegrun AS.

Clin Cancer Res. 2004 Aug 15;10(16):5464-71.

3.

p53 is an independent predictor of tumor recurrence and progression after nephrectomy in patients with localized renal cell carcinoma.

Shvarts O, Seligson D, Lam J, Shi T, Horvath S, Figlin R, Belldegrun A, Pantuck AJ.

J Urol. 2005 Mar;173(3):725-8.

PMID:
15711252
4.

Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.

Klatte T, Seligson DB, LaRochelle J, Shuch B, Said JW, Riggs SB, Zomorodian N, Kabbinavar FF, Pantuck AJ, Belldegrun AS.

Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):894-900. doi: 10.1158/1055-9965.EPI-08-0786. Epub 2009 Feb 24.

5.

Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma.

Bui MH, Visapaa H, Seligson D, Kim H, Han KR, Huang Y, Horvath S, Stanbridge EJ, Palotie A, Figlin RA, Belldegrun AS.

J Urol. 2004 Jun;171(6 Pt 1):2461-6.

PMID:
15126876
6.

Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.

Lam JS, Shvarts O, Said JW, Pantuck AJ, Seligson DB, Aldridge ME, Bui MH, Liu X, Horvath S, Figlin RA, Belldegrun AS.

Cancer. 2005 Jun 15;103(12):2517-25.

7.

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.

Bui MH, Seligson D, Han KR, Pantuck AJ, Dorey FJ, Huang Y, Horvath S, Leibovich BC, Chopra S, Liao SY, Stanbridge E, Lerman MI, Palotie A, Figlin RA, Belldegrun AS.

Clin Cancer Res. 2003 Feb;9(2):802-11.

8.

Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma.

Visapää H, Bui M, Huang Y, Seligson D, Tsai H, Pantuck A, Figlin R, Rao JY, Belldegrun A, Horvath S, Palotie A.

Urology. 2003 Apr;61(4):845-50.

PMID:
12670587
9.

Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.

Phuoc NB, Ehara H, Gotoh T, Nakano M, Yokoi S, Deguchi T, Hirose Y.

Urology. 2007 May;69(5):843-8.

PMID:
17482919
10.
11.

Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.

Kassouf W, Sanchez-Ortiz R, Tamboli P, Tannir N, Jonasch E, Merchant MM, Matin S, Swanson DA, Wood CG.

J Urol. 2007 Nov;178(5):1896-900. Epub 2007 Sep 17.

PMID:
17868729
12.

Vascular cell adhesion molecule 1 predicts cancer-free survival in clear cell renal carcinoma patients.

Shioi K, Komiya A, Hattori K, Huang Y, Sano F, Murakami T, Nakaigawa N, Kishida T, Kubota Y, Nagashima Y, Yao M.

Clin Cancer Res. 2006 Dec 15;12(24):7339-46.

13.

C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy.

Casamassima A, Picciariello M, Quaranta M, Berardino R, Ranieri C, Paradiso A, Lorusso V, Guida M.

J Urol. 2005 Jan;173(1):52-5.

PMID:
15592024
14.

Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.

Wagner B, Patard JJ, Méjean A, Bensalah K, Verhoest G, Zigeuner R, Ficarra V, Tostain J, Mulders P, Chautard D, Descotes JL, de la Taille A, Salomon L, Prayer-Galetti T, Cindolo L, Valéri A, Meyer N, Jacqmin D, Lang H.

Eur Urol. 2009 Feb;55(2):452-9. doi: 10.1016/j.eururo.2008.07.053. Epub 2008 Aug 5.

PMID:
18692951
15.
16.

Prognostic factors for survival in metastatic renal cell carcinoma: retrospective analysis from 109 consecutive patients.

Citterio G, Bertuzzi A, Tresoldi M, Galli L, Di Lucca G, Scaglietti U, Rugarli C.

Eur Urol. 1997;31(3):286-91.

PMID:
9129917
17.

The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.

Zubac DP, Bostad L, Kihl B, Seidal T, Wentzel-Larsen T, Haukaas SA.

J Urol. 2009 Nov;182(5):2144-9. doi: 10.1016/j.juro.2009.07.015. Epub 2009 Sep 15.

PMID:
19758660
18.

Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma.

Seligson DB, Pantuck AJ, Liu X, Huang Y, Horvath S, Bui MH, Han KR, Correa AJ, Eeva M, Tze S, Belldegrun AS, Figlin RA.

Clin Cancer Res. 2004 Apr 15;10(8):2659-69.

19.

Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma.

Lee SE, Byun SS, Oh JK, Lee SC, Chang IH, Choe G, Hong SK.

J Urol. 2006 Oct;176(4 Pt 1):1332-7; discussion 1337-8.

PMID:
16952624
20.

Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.

Klatte T, Seligson DB, Riggs SB, Leppert JT, Berkman MK, Kleid MD, Yu H, Kabbinavar FF, Pantuck AJ, Belldegrun AS.

Clin Cancer Res. 2007 Dec 15;13(24):7388-93.

Items per page

Supplemental Content

Write to the Help Desk